Amy C. Peterson's Net Worth

$66.9 Million

Estimate Recalculated Feb 10, 2025 11:00PM EST

Who is Amy C. Peterson

Amy C. Peterson has an estimated net worth of $66.9 Million. This is based on reported shares across multiple companies, which include BeiGene, Ltd., CytomX Therapeutics, Inc., and EXELIXIS, INC..

SEC CIK

Amy C. Peterson's CIK is 0001682735

Past Insider Trading and Trends

2018 was Amy C. Peterson's most active year for acquiring shares with 7 total transactions. Amy C. Peterson's most active month to acquire stocks was the month of January. 2018 was Amy C. Peterson's most active year for disposing of shares, totalling 41 transactions. Amy C. Peterson's most active month to dispose stocks was the month of October. 2018 saw Amy C. Peterson paying a total of $1,746,000.00 for 414,744 shares, this is the most they've acquired in one year. In 2018 Amy C. Peterson cashed out on 845,769 shares for a total of $8,457,291.67, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

BeiGene, Ltd.

CMO, Immuno-oncology
Updated Dec 19, 2018
Form 4
-24.07%
-260.00K
$81.39
-$2.09M
Dec 19, 2018
1.01M
Sale
ScheduledDec 17 - Dec 18
Form 4
-32.50%
-520.00K
$74.65
-$3.64M
Nov 13, 2018
1.27M
Sale
ScheduledNov 08 - Nov 12
Form 4
-100.00%
-5.77K
$169.12
-$975.67K
Aug 24, 2018
194.57K
Sale
ScheduledAug 23
Form 4
157.66%
354.74K
Jun 28, 2018
579.75K
Grant
Jun 26
Form 4
-100.00%
-3.60K
$82.96
-$298.75K
Nov 15, 2017
225.00K
Sale
ScheduledNov 13
Form 4
-9.40%
-28.18K
$5.39
-$151.83K
Aug 24, 2017
271.82K
Tax
Aug 22
Form 4
1.02M
Jun 29, 2017
1.02M
Grant
Jun 27
Form 4
1.90M
Aug 24, 2016
1.90M
Grant
Aug 22
Form 3
Aug 24, 2016
Showing 9 results

CytomX Therapeutics, Inc.

EVP, Chief Development Officer
Updated Mar 20, 2023
Form 4
-6.79%
-4.26K
$1.98
-$8.42K
Mar 20, 2023
58.43K
Sale
Mar 16
Form 4
25.00%
12.54K
$1.42
-$10.61K
Jul 21, 2022
62.69K
Grant
Jul 19 - Jul 20
Form 4
3,737.74%
240.00K
Feb 04, 2022
246.42K
Grant
Feb 02
Form 4
90.00K
Oct 26, 2021
90.00K
Grant
Oct 24
Form 4
107.06%
3.32K
$6.09
$20.21K
Jun 08, 2021
6.42K
Grant
May 31
Form 4
250.00K
Mar 02, 2021
250.00K
Grant
Feb 26
Form 4
3.10K
$6.39
$19.82K
Dec 07, 2020
3.10K
Grant
Nov 30
Form 4
25.00K
Feb 19, 2020
25.00K
Grant
Feb 14
Form 4
400.00K
Oct 16, 2019
400.00K
Grant
Oct 15
Form 3
Oct 16, 2019
Showing 10 results

EXELIXIS, INC.

EVP Prod Dev & Med Aff & CMO
Updated Feb 27, 2024
Form 4
34.22%
82.12K
Feb 27, 2024
322.12K
Grant
Feb 23
Form 4
400.00K
Aug 25, 2023
400.00K
Grant
Aug 24
Form 3
Aug 25, 2023
Showing 3 results